公司资料
Greenwich LifeSciences 股价、新闻与催化剂
- 股票代码:
- GLSI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
18.39 USD (+17.66%)
收盘价
最后更新: 2026年9月17日
357M USD
市值
股价为何变动
截至 2026年9月17日，GLSI 上涨 17.7%，收于 $18.39。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Greenwich LifeSciences is an immunotherapy company focused on cancer vaccines and breast-cancer treatment. Its story is built around a narrow but potentially differentiated oncology program.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Greenwich sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, target validation, and the possibility of creating a focused cancer-immunotherapy franchise.
生物医药行业定位
Greenwich is a high-catalyst oncology name whose stock is very sensitive to trial and translational outcomes.
未来催化剂
- Greenwich’s catalysts are its breast-cancer immunotherapy program and any update that shows the platform still has a path forward. The next development step matters because the story is still highly data-dependent.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。